Remedium Bio

Raising $2.3M (in an expanded Seed financing round) to secure pre-clinical proof of concept data (in vitro, ex vivo, and in vivo).

Facebook Twitter LinkedIn

Remedium Bio is a Boston area gene therapy company founded on the fundamental principle that - any disease can be cured. We modularly apply proven technologies to develop novel treatments for diseases with well-characterized pathology. Our lead candidate is the only single injection gene therapy potentially capable of regenerating cartilage in osteoarthritis. Our product is developed around a clinically validated target, proven delivery technique, and established pre-clinical and clinical models.

Ready to Ask For Funding for your company?

Post a Funding Request